Search by
- Parties: The plaintiffs were Amgen Canada Inc and Onyx Therapeutics Inc. The defendant was Natco Pharma (Canada) Inc.
- Subject Matter: This action involved the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Jan. 10, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Download documents
Plaintiff
Defendant
Court
Federal CourtCase Number
T-1775-23Practice Area
Intellectual propertyAmount
Not specified/UnspecifiedWinner
Trial Start Date
25 August 2023